Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.74 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.58 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.58 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | KDM4A | O75164 | 11/20 | 0.40 |
| ▸ | KDM4C | Q9H3R0 | 11/20 | 0.40 |
| ▸ | KDM5A | P29375 | 1/20 | 0.40 |
| ▸ | KDM7A | Q6ZMT4 | 1/20 | 0.40 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.40 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3189950 | 0.97 | ALDH1A1 (0.70) | ALDH1A1CHRNB2CHRNB4CHRNA4LMNA | |
| SCHEMBL5948495 | 0.93 | ALDH1A1 (0.74) | ALDH1A1CHRNB2CHRNB4CHRNA4LMNA | |
| SCHEMBL812501 | 0.89 | ALDH1A1 (0.61) | ALDH1A1CHRNB2CHRNB4CHRNA4LMNA | |
| SCHEMBL1049266 | 0.89 | ALDH1A1 (0.61) | ALDH1A1CHRNB2CHRNB4CHRNA4LMNA | |
| SCHEMBL630064 | 0.89 | ALDH1A1 (0.85) | ALDH1A1CHRNB2CHRNB4CHRNA4 | |
| SCHEMBL1049265 | 0.89 | ALDH1A1 (0.61) | ALDH1A1CHRNB2CHRNB4CHRNA4LMNA | |
| SCHEMBL1291925 | 0.89 | ALDH1A1 (0.61) | ALDH1A1CHRNB2CHRNB4CHRNA4LMNA | |
| SCHEMBL740728 | 0.87 | ALDH1A1 (0.81) | ALDH1A1 | |
| SCHEMBL22406917 | 0.87 | ALDH1A1 (0.81) | ALDH1A1 | |
| SCHEMBL15254336 | 0.87 | ALDH1A1 (0.58) | ALDH1A1CHRNB2CHRNB4CHRNA4HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9878975-B2 | Catalytic hydrogenation for producing amines from carboxylic acid amides, carboxylic acid diamides, di-, tri-, or polypeptides, or peptide amides | EVONIK DEGUSSA GMBH (DE) | 2018-01-30 | — | — | US | claimed |
| US-5476743-A | Thermoplastic resin, a charge director, a liquid component, an additive selected from cyclic carbonates, cyclic sulfones, cyclic sulfoxides and organic amides, pigments, and a charge adjuvant | XEROX CORPORATION (US) | 1995-12-19 | — | — | US | claimed |
| EP-0304134-A2 | Magnetic resin composition | DSM N.V. (NL) | 1989-02-22 | — | — | EP | claimed |
| US-12590089-B2 | Processes for preparing toll-like receptor modulator compounds | GILEAD SCIENCES, INC. (US) | 2026-03-31 | — | — | US | disclosed |
| CN-118871522-A | High performance polymer composition containing carbon nanostructures | 提克纳有限责任公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-118435715-A | EMI shielding polymer composition | 提克纳有限责任公司 | 2024-08-02 | — | — | CN | disclosed |
| CN-118401534-A | Flame retardant thermoplastic polymer composition | 国际人造丝公司 | 2024-07-26 | — | — | CN | disclosed |
| CN-117898032-A | Multilayer composite for EMI shielding | 提克纳有限责任公司 | 2024-04-16 | — | — | CN | disclosed |
| CN-116769222-A | Polyamide resin foam particles for fiber-reinforced resin composite core material, and fiber-reinforced resin composite | 株式会社JSP | 2023-09-19 | — | — | CN | disclosed |
| US-20220274985-A1 | PROCESSES FOR PREPARING TOLL-LIKE RECEPTOR MODULATOR COMPOUNDS | GILEAD SCIENCES, INC. | 2022-09-01 | — | — | US | disclosed |
| EP-3990455-A1 | PROCESSES FOR PREPARING TOLL-LIKE RECEPTOR MODULATOR COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2022-05-04 | — | — | EP | disclosed |
| US-4751272-A | POLYMERIZING TRIOXANE AND CYCLIC ETHER; BORON TRIFLUORIDE CATALYST | TORAY INDUSTRIES, INC. (JP) | 1988-06-14 | — | — | US | disclosed |
| EP-0244245-A2 | Process for producing oxymethylene copolymer and resinous composition | TORAY INDUSTRIES, INC. (JP) | 1987-11-04 | — | — | EP | disclosed |
| US-4634530-A | Chemical modification of preformed polybenzimidazole semipermeable membrane | CELANESE CORPORATION (US) | 1987-01-06 | — | — | US | disclosed |
| EP-0097615-B1 | PREPARATION OF CYANOBENZOIC-ACID ESTERS | CIBA-GEIGY AG (CH) | 1985-11-21 | — | — | EP | disclosed |
| EP-0144467-A1 | Catalyst system and its use in hydrogenation of N,N-disubstituted amides to amines | THE PROCTER & GAMBLE COMPANY (US) | 1985-06-19 | — | — | EP | disclosed |
| US-4448998-A | COPPER CHROMITE AND ZEOLITE | THE PROCTER & GAMBLE COMPANY (US) | 1984-05-15 | — | — | US | disclosed |
| EP-0097615-A1 | Preparation of cyanobenzoic-acid esters | CIBA-GEIGY AG (CH) | 1984-01-04 | — | — | EP | disclosed |
| US-4212952-A | N,N,N',N'-Tetramethyl-αω-polymethlenediamines as catalysts for the preparation of urethane foams | UNION CARBIDE CORPORATION (US) | 1980-07-15 | — | — | US | disclosed |
| EP-0013083-A1 | The use of N,N,N',N'-tetramethyl-alpha-omega-polymethylene diamines as catalysts for the preparation of urethane foams, and urethane foams prepared therewith | UNION CARBIDE CORPORATION (US) | 1980-07-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12590089-B2 | Processes for preparing toll-like receptor modulator compounds | TLR8, MYD88, TLR6 | ALDH1A1 3917/4885CHRNB2 2293/4885CHRNB4 3143/4885 |
| US-20220274985-A1 | PROCESSES FOR PREPARING TOLL-LIKE RECEPTOR MODULATOR COMPOUNDS | TLR4, TLR3, TLR6 | ALDH1A1 4031/4885CHRNB2 1453/4885CHRNB4 1475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.